Ming Tang

ORCID: 0000-0002-7739-8913
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cancer Immunotherapy and Biomarkers
  • Cancer Genomics and Diagnostics
  • Single-cell and spatial transcriptomics
  • Genomics and Chromatin Dynamics
  • Immune Cell Function and Interaction
  • RNA modifications and cancer
  • Immunotherapy and Immune Responses
  • Epigenetics and DNA Methylation
  • Tannin, Tannase and Anticancer Activities
  • Pancreatic and Hepatic Oncology Research
  • Microbial Metabolism and Applications
  • Viral-associated cancers and disorders
  • Monoclonal and Polyclonal Antibodies Research
  • Genomics and Phylogenetic Studies
  • Protein Degradation and Inhibitors
  • Ubiquitin and proteasome pathways
  • Complement system in diseases
  • Lung Cancer Treatments and Mutations
  • Hippo pathway signaling and YAP/TAZ
  • Hepatitis Viruses Studies and Epidemiology
  • Ferroptosis and cancer prognosis
  • Lymphoma Diagnosis and Treatment
  • Immune cells in cancer
  • Radiomics and Machine Learning in Medical Imaging
  • interferon and immune responses

Immunitas Therapeutics (United States)
2023-2024

National Center for Nanoscience and Technology
2023-2024

Dana-Farber Cancer Institute
2020-2024

Guizhou Normal University
2024

First People's Hospital of Yunnan Province
2023-2024

Kunming University of Science and Technology
2023-2024

Sun Yat-sen University
2023-2024

Sun Yat-sen University Cancer Center
2023-2024

Dalian Medical University
2020-2024

Chongqing Medical University
2020-2024

A. Gordon Robertson Juliann Shih Christina Yau Ewan A. Gibb Junna Oba and 95 more Karen Mungall Julian M. Hess Vladislav Uzunangelov Vonn Walter Ludmila Danilova Tara M. Lichtenberg Melanie H. Kucherlapati Patrick K. Kimes Ming Tang Alexander Penson Özgün Babur Rehan Akbani Christopher A. Bristow Katherine A. Hoadley Lisa Iype Matthew T. Chang Andrew D. Cherniack Christopher C. Benz Gordon B. Mills Roel G.W. Verhaak Klaus Griewank Ina Felau Jean C. Zenklusen Hui Shen Lynn Schoenfield Alexander J. Lazar Mohamed H. Abdel‐Rahman Sergio Román-Román Marc‐Henri Stern Colleen M. Cebulla Michelle D. Williams Martine J. Jager Sarah E. Coupland Bita Esmaeli Cyriac Kandoth Scott E. Woodman Mohamed H. Abdel‐Rahman Rehan Akbani Adrian Ally J. Todd Auman Özgün Babur Miruna Balasundaram Saianand Balu Christopher C. Benz Rameen Beroukhim İnanç Birol Tom Bodenheimer Jay Bowen Reanne Bowlby Christopher A. Bristow Denise Brooks Rebecca Carlsen Colleen M. Cebulla Matthew T. Chang Andrew D. Cherniack Lynda Chin Juok Cho Eric Chuah Sudha Chudamani Carrie Cibulskis Kristian Cibulskis Leslie Cope Sarah E. Coupland Ludmila Danilova Timothy Defreitas John A. Demchok Laurence Desjardins Noreen Dhalla Bita Esmaeli Ina Felau Martin L. Ferguson Scott Frazer Stacey Gabriel Julie M. Gastier‐Foster Nils Gehlenborg Mark Gerken Hui Shen Gad Getz Ewan A. Gibb Klaus Griewank Elizabeth A. Grimm D. Neil Hayes Apurva M. Hegde David I. Heiman Carmen Helsel Julian M. Hess Katherine A. Hoadley Shital Hobensack Robert A. Holt Alan P. Hoyle Xin Hu Carolyn M. Hutter Martine J. Jager Joshua M. Stuart Corbin D. Jones

10.1016/j.ccell.2017.07.003 article EN cc-by-nc-nd Cancer Cell 2017-08-01

Gene fusion represents a class of molecular aberrations in cancer and has been exploited for therapeutic purposes. In this paper we describe TumorFusions, data portal that catalogues 20 731 gene fusions detected 9966 well characterized samples 648 normal specimens from The Cancer Genome Atlas (TCGA). spans 33 types TCGA. Fusion transcripts were identified via uniform pipeline, including filtering against list 3838 transcript panel non-neoplastic samples. Fusions mapped to somatic DNA...

10.1093/nar/gkx1018 article EN cc-by-nc Nucleic Acids Research 2017-10-17

Abstract Immune checkpoint therapies exhibit impressive efficacy in some patients with melanoma or lung cancer, but the lack of response most cases presses question how general can be improved. In addressing this question, we generated a preclinical tumor model to study anti-PD-1 resistance by vivo passaging Kras-mutated, p53-deficient murine cancer cells (p53R172HΔg/+K-rasLA1/+) syngeneic host exposed repetitive dosing anti-mouse PD-1 antibodies. PD-L1 (CD274) expression did not differ...

10.1158/0008-5472.can-15-3142 article EN Cancer Research 2016-11-08

Abstract We present Model-based AnalysEs of Transcriptome and RegulOme (MAESTRO), a comprehensive open-source computational workflow ( http://github.com/liulab-dfci/MAESTRO ) for the integrative analyses single-cell RNA-seq (scRNA-seq) ATAC-seq (scATAC-seq) data from multiple platforms. MAESTRO provides functions pre-processing, alignment, quality control, expression chromatin accessibility quantification, clustering, differential analysis, annotation. By modeling gene regulatory potential...

10.1186/s13059-020-02116-x article EN cc-by Genome biology 2020-08-07

Oncogenic KRAS (KRAS*) is a key tumor maintenance gene in pancreatic ductal adenocarcinoma (PDAC), motivating pharmacologic targeting of KRAS* and its effectors. Here, we explored mechanisms involving the microenvironment (TME) as potential basis for resistance to KRAS*. Using inducible Kras G12D;Trp53 -/- PDAC mouse model, gain-of-function screens epigenetic regulators identified HDAC5 top hit enabling independent growth. HDAC5-driven escaper tumors showed prominent neutrophil-to-macrophage...

10.1158/2159-8290.cd-19-0597 article EN Cancer Discovery 2020-04-27

Abstract As sequencing depth of chromatin studies continually grows deeper for sensitive profiling regulatory elements or spatial structures, aligning and preprocessing these data have become the bottleneck analysis. Here we present Chromap, an ultrafast method high throughput profiles. Chromap is comparable to BWA-MEM Bowtie2 in alignment accuracy over 10 times faster than traditional workflows on bulk ChIP-seq/Hi-C profiles 10x Genomics’ CellRanger v2.0.0 pipeline single-cell ATAC-seq

10.1038/s41467-021-26865-w article EN cc-by Nature Communications 2021-11-12

Carcinoma cells can acquire increased motility and invasiveness through epithelial-to-mesenchymal transition (EMT). However, the significance of EMT in cancer metastasis has been controversial, exact fates functions vivo remain inadequately understood. Here, we tracked epithelial that underwent inducible or spontaneous various tumor transplantation models. Unlike cells, majority were specifically located perivascular space closely associated with blood vessels. markedly activated multiple...

10.1172/jci86623 article EN Journal of Clinical Investigation 2016-10-09

Abstract Renal fibrosis is the final manifestation of various chronic kidney diseases, and no effective therapy available to prevent or reverse it. Celastrol, a triterpene that derived from traditional Chinese medicine, known potent anti-fibrotic agent. However, underlying mechanisms action celastrol on renal remain unknown. In this study, we found treatment remarkably attenuated unilateral ureteral obstruction (UUO)-induced mouse fibrosis. This was evidenced by significant reduction in...

10.1038/s41419-018-0666-y article EN cc-by Cell Death and Disease 2018-05-22

Abstract Background Although native to North America, the invasion of aphid-like grape phylloxera Daktulosphaira vitifoliae across globe altered course cultivation. For past 150 years, viticulture relied on grafting-resistant American Vitis species as rootstocks, thereby limiting genetic stocks tolerant other stressors such pathogens and climate change. Limited understanding insect genetics resulted in successive outbreaks when rootstocks failed. Here we report 294-Mb genome D. a basic tool...

10.1186/s12915-020-00820-5 article EN cc-by BMC Biology 2020-07-22

Enhancer aberrations are beginning to emerge as a key epigenetic feature of colorectal cancers (CRC), however, comprehensive knowledge chromatin state patterns in tumour progression, heterogeneity these and imparted therapeutic opportunities remain poorly described.We performed epigenomic characterisation by mapping 222 profiles from 69 samples (33 adenocarcinomas, 4 adenomas, 21 matched normal tissues 11 colon cancer cell lines) for six histone modification marks: H3K4me3 Pol II-bound...

10.1136/gutjnl-2020-322835 article EN Gut 2021-05-31

Background Population growth, aging, and major alterations in epidemiologic trends inadvertently modulate the status of rheumatic heart disease (RHD) epidemiology. This investigation predicted RHD burden pattern temporal to provide evidence. Methods Results Prevalence, mortality, disability-adjusted life-years data for were obtained from GBD (Global Burden Disease) study. We performed decomposition analysis frontier assess variations 1990 2019. In 2019, there >40.50 million cases worldwide,...

10.1161/jaha.122.028921 article EN cc-by-nc-nd Journal of the American Heart Association 2023-06-27

Predictive biomarkers of immune checkpoint inhibitor (ICI) efficacy are currently lacking for non-small cell lung cancer (NSCLC). Here, we describe the results from Anti-PD-1 Response Prediction DREAM Challenge, a crowdsourced initiative that enabled assessment predictive models by using data two randomized controlled clinical trials (RCTs) ICIs in first-line metastatic NSCLC.

10.1186/s12967-023-04705-3 article EN cc-by Journal of Translational Medicine 2024-02-21

A truncated structural protein of hepatitis E virus (HEV), p239, occurs as 23 nm particles consisting partial homodimers. As the latter resemble HEV capsomere structurally and antigenically, it was postulated that recombinant may serve a probe for receptor. This hypothesis supported by findings purified p239 bound penetrated different cell lines are susceptible to HEV, inhibited infection these cells. The binding blocked four six monoclonal antibodies (mAbs) reactive against dimeric domain...

10.1099/vir.0.83308-0 article EN Journal of General Virology 2007-12-18

Although human ZMYND8 has been implicated as a transcriptional co-repressor of multiple targets, global association with active genes and enhancer regions predicts otherwise. Here, we report an additional function in activation through its the P-TEFb complex. Biochemical reconstitution analyses show that ZMYND8, direct CylcinT1, forms minimal ZMYND8-P-TEFb The importance target gene activation, complex recruitment, is demonstrated on chromosomally integrated reporter well native vivo....

10.1016/j.celrep.2018.07.064 article EN cc-by-nc-nd Cell Reports 2018-08-01
Coming Soon ...